期刊文献+

哮喘急性发作患儿外周血免疫细胞及相关因子变化及意义 被引量:2

原文传递
导出
摘要 目的探讨哮喘急性发作患儿外周血免疫细胞及相关因子的变化及意义。方法分别取107例哮喘患儿(哮喘组)治疗前(急性发作)和治疗后(哮喘缓解)外周静脉血,进行淋巴细胞表面IL-2受体(mIL-2R)、血浆可溶性IL-2受体(sIL-2R)、T淋巴细胞亚群检测。同时,选择20例年龄匹配的健康儿童作为对照组,10例有长期间歇性哮喘的患儿作为稳定哮喘组,均取外周静脉血,进行上述指标检测。结果治疗前,哮喘组CD3+、CD4+、CD8+细胞比率较对照组升高,差异有统计学意义(P均<0.05);CD4+细胞比率较稳定哮喘组高,差异有统计学意义(P<0.05)。治疗后,哮喘组CD3+、CD4+、CD8+细胞比率均较治疗前降低,差异有统计学意义(P均<0.01)。哮喘组治疗前mIL-2R表达量高于对照组,差异有统计学意义(P<0.05),哮喘组治疗后mIL-2R表达量低于治疗前,差异有统计学意义(P<0.01)。哮喘组治疗前血浆sIL-2R、IgE含量较对照组和稳定哮喘组显著升高,差异有统计学意义(P均<0.01)。哮喘组治疗后血浆IgE仍高于对照组(P<0.01)和稳定哮喘组(P<0.05);血浆sIL-2R降低到正常范围。结论哮喘急性发作患儿外周血CD3+、CD4+、CD8+淋巴细胞比率,淋巴细胞表面mIL-2R,血浆sIL-2R、IgE含量,均显著升高,这些指标均可作为哮喘急性发作的敏感标志物。
作者 王霖
出处 《慢性病学杂志》 2014年第3期198-200,共3页 Chronic Pathematology Journal
  • 相关文献

参考文献3

  • 1Pamela R. Wood,Vanessa L. Hill,Margaret L. Burks,Jay I. Peters,Harjinder Singh,Thirumalai R. Kannan,Shruthi Vale,Marianna P. Cagle,Molly F.R. Principe,Joel B. Baseman,Edward G. Brooks.Mycoplasma pneumoniae in children with acute and refractory asthma[J].Annals of Allergy Asthma & Immunology.2013(5)
  • 2Holtzman,Michael J.Asthma as a chronic disease of the innate and adaptive immune systems responding to viruses and allergens[J].EN.2012(8)
  • 3Matthew Lotz,R. Peebles.Mechanisms of Respiratory Syncytial Virus Modulation of Airway Immune Responses[J].Current Allergy and Asthma Reports.2012(5)

共引文献2

同被引文献28

  • 1Bahceciler NN,Hocaoglu AB,Galip N.A milestone in house dust-mite-allergen immunotherapy:the new sublingual tablet S-524101(actair)[J].Expert Rev Vaccines,2014,13(12):1427-1438.
  • 2Ciepiela O,Zawadzka-Krajewska A,KotuaI,et al.The influence of sublingual immunotherapy on several parameters of immunological response in children suffering from atopic asthma and allergic rhinitis depending on asthma features[J].Pneumonol Alergol Pol,2014,82(6):503-510.
  • 3Larenas Linnemann DE,Blaiss MS.Selection of patients for sublingual versus subcutaneous immunotherapy[J].Immunotherapy,2014,6(7):871-884.
  • 4Irani C,Saleh RA,Jammal M,et al.High-dose sublingual immunotherapy in patients with uncontrolled allergic rhinitis sensitized to pollen:a real-life clinical study[J].Int Forum Allergy Rhinol,2014,4(10):802-807.
  • 5Didier A,Wahn U,Horak F,et al.Five-grass-pollen sublingual immunotherapy tablet for the treatment of grass-pollen-inducedallergic rhinoconjunctivitis:5years of experience[J].Expert Rev Clin Immunol,2014,10(10):1309-1324.
  • 6Bozek A,Kolodziejczyk K,Warkocka-Szoltysek B,et al.Grass pollen sublingual immunotherapy:a double-blind,placebo-controlled study in elderly patients with seasonal allergic rhinitis[J].Am J Rhinol Allergy,2014,28(5):423-427.
  • 7Pleskovic N,Bartholow A,Skoner DP.Sublingual immunotherapy in children:the recent experiences[J].Curr Opin Allergy Clin Immunol,2014,14(6):582-590.
  • 8Cuppari C,Leonardi S,Manti S,et al.Allergen immunotherapy,routes of administration and cytokine networks:an update[J].Immunotherapy,2014,6(6):775-786.
  • 9de Blay F,Kuna P,Prieto L,et al.SQ HDM SLIT-tablet(ALK)in treatment of asthma--post hoc results from a randomised trial[J].Respir Med,2014,108(10):1430-1437.
  • 10Leatherman B,Skoner DP,Hadley JA,et al.The Allergies,Immunotherapy,and RhinoconjunctivitiS(AIRS)survey:provider practices and beliefs about allergen immunotherapy[J].Int Forum Allergy Rhinol,2014,4(10):779-788.

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部